Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Innodata
INOD
$1.81B
| $25.8M | 0.01% |
652,860
-127,376
| -16% | -$4.01M |
|
527
Envista
NVST
$4.62B
| $25.8M | 0.01% |
1,335,972
-33,838
| -2% | -$669K |
|
528
Pfizer
PFE
$143B
| $25.4M | 0.01% |
958,315
+427,886
| +81% | +$11.6M |
|
529
RenaissanceRe
RNR
$13.8B
| $25.2M | 0.01% |
101,172
-11,830
| -10% | -$3.18M |
|
|
SEPN
530
Septerna Inc
SEPN
$1.51B
| $25.1M | 0.01% |
+1,096,302
| New | +$25.9M |
|
531
Atlassian
TEAM
$26.5B
| $25M | 0.01% |
102,531
+86,981
| +559% | +$19.9M |
|
532
Larimar Therapeutics
LRMR
$377M
| $24.9M | 0.01% |
6,443,286
+876,431
| +16% | +$5.79M |
|
533
BlackLine
BL
$1.9B
| $24.4M | 0.01% |
402,039
+151
| +0% | +$9.01K |
|
534
Tyra Biosciences
TYRA
$1.85B
| $24.3M | 0.01% |
1,746,320
+679,124
| +64% | +$12.3M |
|
535
Xometry
XMTR
$4.47B
| $24.2M | 0.01% |
567,632
-88,207
| -13% | -$2.49M |
|
536
Black Hills Corp
BKH
$5.55B
| $24.2M | 0.01% |
413,447
+2
| +0% | +$122 |
|
537
Unum
UNM
$13.4B
| $24.1M | 0.01% |
330,081
+195,947
| +146% | +$13.5M |
|
538
Franklin FTSE Japan ETF
FLJP
$3.86B
| $24M | 0.01% |
840,222
-39,364
| -4% | -$1.15M |
|
539
AAR Corp
AIR
$5.4B
| $23.9M | 0.01% |
389,313
+39,505
| +11% | +$2.53M |
|
540
Dianthus Therapeutics
DNTH
$5.69B
| $23.6M | 0.01% |
1,085,648
+136,314
| +14% | +$3.51M |
|
541
Chubb
CB
$140B
| $23.5M | 0.01% |
85,112
+15,127
| +22% | +$4.3M |
|
542
Paychex
PAYX
$43.4B
| $23.5M | 0.01% |
167,476
-93,114
| -36% | -$13.2M |
|
543
Lamb Weston
LW
$7.42B
| $23.5M | 0.01% |
351,364
+28,508
| +9% | +$2.13M |
|
544
Monopar Therapeutics
MNPR
$720M
| $23.4M | 0.01% |
+1,046,899
| New | +$17.6M |
|
545
Workiva
WK
$3.45B
| $23.4M | 0.01% |
213,908
+77
| +0% | +$7.1K |
|
546
McCormick & Company Non-Voting
MKC
$14B
| $23.2M | 0.01% |
304,191
-6,868
| -2% | -$540K |
|
547
Medpace
MEDP
$16.3B
| $23M | 0.01% |
69,207
+25,089
| +57% | +$8.51M |
|
548
Kornit Digital
KRNT
$677M
| $22.9M | 0.01% |
740,069
-13,407
| -2% | -$385K |
|
549
Caterpillar
CAT
$361B
| $22.8M | 0.01% |
62,791
-1,030
| -2% | -$399K |
|
|
AVDX
550
DELISTED
AvidXchange
AVDX
| $22.7M | 0.01% |
2,199,833
-242,460
| -10% | -$2.37M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.